Incidence of new-onset diabetes with 1 mg versus 4 mg pitavastatin in patients at high risk of developing diabetes during a 3-year follow-up

BACKGROUND: Statin therapy reduces the risk of cardiovascular events across a broad spectrum of patients; however, it increases the risk of new-onset diabetes (NOD). Although the highest dose pitavastatin is considered to not be associated with NOD, there are limited data regarding the impact of lon...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeong, Han Saem, Hong, Soon Jun, Son, Serhim, An, Hyonggin, Kook, Hyungdon, Joo, Hyung Joon, Park, Jae Hyoung, Yu, Cheol Woong, Lim, Do-Sun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6868797/
https://www.ncbi.nlm.nih.gov/pubmed/31752850
http://dx.doi.org/10.1186/s12933-019-0969-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6868797/
https://www.ncbi.nlm.nih.gov/pubmed/31752850
http://dx.doi.org/10.1186/s12933-019-0969-z

Ejemplares similares